ArticleOncology letters2023

Low expression of SEMA4D as a potential predictive molecular marker of poor survival in patients with melanoma combined with liver cancer.

Xiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.